Cargando…

The Potential Protective Role of RUNX1 in Nonalcoholic Fatty Liver Disease

The pathogenic mechanisms underlying nonalcoholic fatty liver disease (NAFLD) are beginning to be understood. RUNX1 is involved in angiogenesis, which is crucial in inflammation, but its role in nonalcoholic steatohepatitis (NASH) remains unclear. The aim of this study was to analyze RUNX1 mRNA hepa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bertran, Laia, Pastor, Angela, Portillo-Carrasquer, Marta, Binetti, Jessica, Aguilar, Carmen, Martínez, Salomé, Vives, Margarita, Sabench, Fàtima, Porras, José Antonio, Riesco, David, Del Castillo, Daniel, Richart, Cristóbal, Auguet, Teresa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156882/ https://www.ncbi.nlm.nih.gov/pubmed/34063472 http://dx.doi.org/10.3390/ijms22105239

Ejemplares similares

Deregulation of Secreted Frizzled-Related Protein 5 in Nonalcoholic Fatty Liver Disease Associated with Obesity
por: Bertran, Laia, et al.
Publicado: (2021)

Increased Secreted Frizzled-Related Protein 5 mRNA Expression in the Adipose Tissue of Women with Nonalcoholic Fatty Liver Disease Associated with Obesity
por: Bertran, Laia, et al.
Publicado: (2022)

New Insights of OLFM2 and OLFM4 in Gut-Liver Axis and Their Potential Involvement in Nonalcoholic Fatty Liver Disease
por: Bertran, Laia, et al.
Publicado: (2022)

Expression of Jejunal Taste Receptors in Women with Morbid Obesity
por: Bertran, Laia, et al.
Publicado: (2021)

Relationship between IL-8 Circulating Levels and TLR2 Hepatic Expression in Women with Morbid Obesity and Nonalcoholic Steatohepatitis
por: Auguet, Teresa, et al.
Publicado: (2020)

The Role of Olfactomedin 2 in the Adipose Tissue–Liver Axis and Its Implication in Obesity-Associated Nonalcoholic Fatty Liver Disease
por: Barrientos-Riosalido, Andrea, et al.
Publicado: (2023)

Identification of the Potential Molecular Mechanisms Linking RUNX1 Activity with Nonalcoholic Fatty Liver Disease, by Means of Systems Biology
por: Bertran, Laia, et al.
Publicado: (2022)

Circulating Levels of Pro-Neurotensin and Its Relationship with Nonalcoholic Steatohepatitis and Hepatic Lipid Metabolism
por: Villar, Beatriz, et al.
Publicado: (2021)

Increased Hepatic ATG7 mRNA and ATG7 Protein Expression in Nonalcoholic Steatohepatitis Associated with Obesity
por: Barrientos-Riosalido, Andrea, et al.
Publicado: (2023)

Expression of STING in Women with Morbid Obesity and Nonalcoholic Fatty Liver Disease
por: Bertran, Laia, et al.
Publicado: (2023)

Deregulated Serotonin Pathway in Women with Morbid Obesity and NAFLD
por: Binetti, Jessica, et al.
Publicado: (2020)

LC/MS-Based Untargeted Metabolomics Study in Women with Nonalcoholic Steatohepatitis Associated with Morbid Obesity
por: Bertran, Laia, et al.
Publicado: (2023)

Hepcidin in morbidly obese women with non-alcoholic fatty liver disease
por: Auguet, Teresa, et al.
Publicado: (2017)

Are Ingested or Inhaled Microplastics Involved in Nonalcoholic Fatty Liver Disease?
por: Auguet, Teresa, et al.
Publicado: (2022)

Endocannabinoid Receptors Gene Expression in Morbidly Obese Women with Nonalcoholic Fatty Liver Disease
por: Auguet, Teresa, et al.
Publicado: (2014)

LC/MS-Based Untargeted Metabolomics Analysis in Women with Morbid Obesity and Associated Type 2 Diabetes Mellitus
por: Auguet, Teresa, et al.
Publicado: (2023)

miR33a/miR33b* and miR122 as Possible Contributors to Hepatic Lipid Metabolism in Obese Women with Nonalcoholic Fatty Liver Disease
por: Auguet, Teresa, et al.
Publicado: (2016)

Altered Fatty Acid Metabolism-Related Gene Expression in Liver from Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease
por: Auguet, Teresa, et al.
Publicado: (2014)

Gut Microbiota-Derived Mediators as Potential Markers in Nonalcoholic Fatty Liver Disease
por: Aragonès, Gemma, et al.
Publicado: (2019)

PNPLA3 Expression Is Related to Liver Steatosis in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease
por: Aragonès, Gemma, et al.
Publicado: (2016)

Downregulation of de Novo Fatty Acid Synthesis in Subcutaneous Adipose Tissue of Moderately Obese Women
por: Guiu-Jurado, Esther, et al.
Publicado: (2015)

New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women
por: Auguet, Teresa, et al.
Publicado: (2011)

Increased Circulating Levels of Alpha-Ketoglutarate in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease
por: Aragonès, Gemma, et al.
Publicado: (2016)

Clinical and Biomarker Profile Responses to Rehabilitation Treatment in Patients with Long COVID Characterized by Chronic Fatigue
por: Binetti, Jessica, et al.
Publicado: (2023)

Interleukin-17A Gene Expression in Morbidly Obese Women
por: Zapata-Gonzalez, Fernando, et al.
Publicado: (2015)

Resistin and IL-15 as Predictors of Invasive Mechanical Ventilation in COVID-19 Pneumonia Irrespective of the Presence of Obesity and Metabolic Syndrome
por: Perpiñan, Carles, et al.
Publicado: (2022)

Predictive Biomarkers of COVID-19 Severity in SARS-CoV-2 Infected Patients with Obesity and Metabolic Syndrome
por: Perpiñan, Carles, et al.
Publicado: (2021)

Targeted metabolomic approach in men with carotid plaque
por: Auguet, Teresa, et al.
Publicado: (2018)

Molecular pathways in non-alcoholic fatty liver disease
por: Berlanga, Alba, et al.
Publicado: (2014)

Adipo/cytokines in atherosclerotic secretomes: increased visfatin levels in unstable carotid plaque
por: Auguet, Teresa, et al.
Publicado: (2016)

Laparoscopic sleeve gastrectomy alters (1)H-NMR-measured lipoprotein and glycoprotein profile in patients with severe obesity and nonalcoholic fatty liver disease
por: Cabré, Noemí, et al.
Publicado: (2021)

Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in patients with Type 2 Diabetes Mellitus
por: Portillo-Sanchez, Paola, et al.
Publicado: (2016)

Perspectives on youth‐onset nonalcoholic fatty liver disease
por: Castillo‐Leon, Eduardo, et al.
Publicado: (2020)

Cell Models and Omics Techniques for the Study of Nonalcoholic Fatty Liver Disease: Focusing on Stem Cell-Derived Cell Models
por: Pelechá, María, et al.
Publicado: (2021)

Dietary and Nutritional Interventions in Nonalcoholic Fatty Liver Disease in Pediatrics
por: Farías, Camila, et al.
Publicado: (2023)

Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Imajo, Kento, et al.
Publicado: (2013)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease
por: Bebawi, Emmanuel, et al.
Publicado: (2023)

Promising diagnostic biomarkers of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: From clinical proteomics to microbiome
por: Castillo-Castro, Carolina, et al.
Publicado: (2021)

AAV8-mediated Sirt1 gene transfer to the liver prevents high carbohydrate diet-induced nonalcoholic fatty liver disease
por: Vilà, Laia, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_s5vstmsrpjtoh663jfp37f6og9